CGPHF Dividend: Grand Pharmaceutical Group Ltd Yield Insights

CGPHF Financial

Grand Pharmaceutical Group Ltd

At close: Dec 04, 16:00:00 GMT-5

Post-market: Dec 04, 18:23:13 GMT-5

Income

Balance sheet

Cash flow

Annual

Quarterly

CGPHF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	11,704	11,644	10,529	9,562	8,597	6,352
Revenue Growth (YoY)	11%	11%	10%	11%	35%	-4%
Cost of Revenue	4,957	4,906	4,005	3,610	3,350	2,317
Gross Profit	6,747	6,738	6,524	5,951	5,247	4,035
Selling, General & Admin	5,085	4,695	3,860	3,373	3,307	2,563
Research & Development	--	--	--	--	--	--
Operating Expenses	4,771	4,518	3,665	3,205	3,065	2,251
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	2,368	2,852	2,344	2,516	2,785	2,073
Income Tax Expense	316	386	448	418	380	292
Net Income	2,079	2,468	1,879	2,079	2,402	1,792
Net Income Growth	-14%	31%	-10%	-13%	34%	56%
Shares Outstanding (Diluted)	3,501.81	3,501.81	3,507.75	3,542.25	3,548.05	3,445.24
Shares Change (YoY)	0%	0%	-1%	0%	3%	2%
EPS (Diluted)	0.59	0.7	0.53	0.58	0.67	0.52
EPS Growth	-14%	32%	-9%	-13%	30%	51%
Free Cash Flow	1,093	1,276	1,927	757	1,469	1,177
Free Cash Flow Per Share	0.31	0.36	0.54	0.21	0.41	0.34
Gross Margin	57.64%	57.86%	61.96%	62.23%	61.03%	63.52%
Operating Margin	16.87%	19.05%	27.14%	28.71%	25.36%	28.06%
Profit Margin	17.76%	21.19%	17.84%	21.74%	27.93%	28.21%
Free Cash Flow Margin	9.33%	10.95%	18.3%	7.91%	17.08%	18.52%
EBITDA	--	2,722	3,250	3,140	2,520	2,070
EBITDA Margin	--	23.37%	30.86%	32.83%	29.31%	32.58%
D&A For EBITDA	--	503	392	394	339	287
EBIT	1,975	2,219	2,858	2,746	2,181	1,783
EBIT Margin	16.87%	19.05%	27.14%	28.71%	25.36%	28.06%
Effective Tax Rate	13.34%	13.53%	19.11%	16.61%	13.64%	14.08%